Study of Weekly LOC-paclitaxel Injection for Melanoma

Summary

The goal of this clinical research study is to find the highest tolerable dose of LOC-paclitaxel when given to patients with metastatic melanoma. The safety of this drug and if it can control the disease is also being studied.

Timeline

Start

2009-12

Primary completion

2016-02

Completion

2016-02

Outcome

Outcome not reported

Stopped (Enrollment): “Poor Accrual”

Drugs

Indications